Nutrition News

Oral zeaxanthin supplementation of triple combination therapy was found to be comparatively effective and cost-effective to triple therapy alone for neovascular age-related macular degeneration, according to a recent study.

PRN Therapeutics announced the launch of Nuretin, a supplement formulated to manage high blood sugar levels that damage the retinal blood vessels.

Vitamin Science has announced the launch of its third ocular supplement, Dr. Krawitz Dry Eye Support, based on Krawitz Therapeutic Composition for the Treatment of Dry Eye, U.S. patent #7,638,142.

Taking specific antioxidants for at least 1 month significantly increases blood supply within the retinal and retrobulbar vascular beds, with potential protective effects on retinal ganglion cells in patients with open angle glaucoma.

EyePromise announced the introduction of its EyePromise Restore line, with the addition of vitamins B6 and B12, folic acid and coenzyme Q10.

Researchers validated the existence of an interaction between genetics and response to treatment with the Age-Related Eye Disease Study formulation.

The American Academy of Optometry meeting took place in October, but the 300+ hours of lectures and workshops, symposia, and scientific lecture and poster presentations presented over 4 days has provided a wealth of relevant clinical information, especially in the area of dry eye.

Researchers are exploring the relationship between vitamin D, inflammation and dry eye now more than ever before.

Dietary supplementation of lutein, zeaxanthin, omega-3 fatty acids and vitamins does not increase macular pigment optical density (MPOD) in healthy individuals with a family history of age-related macular degeneration and may, therefore, not be effective as a strategy to prevent AMD, according to a study carried out in two French universities.

In 2016, Professor Christophe Baudouin and colleagues published a comprehensive paper on meibomian gland dysfunction, calling it, “the most frequent cause of dry eye disease.